Article by Stock Day Media MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce its wholly-owned subsidiary, MediPharm Labs Inc., has initiated a clinical trial to research and evaluate the effectiveness of MediPharm Labs’ proprietary cannabis-derived medical products ...

Article by Hemp Industry Daily Canadian health authorities say there’s strong demand for over-the-counter, low-THC cannabis such as CBD, and most people want to use it for pain and inflammation if the country were to establish a legal market. That’s the result of a recent Health Canada survey. The agency is considering new rules about the sale of CBD and other “cannabis ...

Article by Sam Riches, Growth Op A new report from the Cannabis Council of Canada, which represents some of the country’s largest licensed producers, including Canopy Growth, Tilray, and Cronos Group, has graded the government’s performance over the first two years of legalization with a ‘C’ average. Led by president and CEO George Smitherman, the former Minister of Health, the council seeks ...

Article by Angela Stelmakowich. Growth Op Medicinal marijuana patients with proper medical documentation still feel they are being pushed toward recreational and unregulated markets to find relief for what ails them, and the situation is worse for patients without documentation. Not only is there a general need to clear systemic barriers — including cost, stigma and other access issues — patients are ...

Article by Marijuana Business Daily Leadership positions in Canada’s regulated marijuana sector continue to be held predominantly by white males, according to a  statistical analysis released this week. The new analysis from the University of Toronto’s Centre on Drug Policy Evaluation included 700 executives and directors across 166 licensed cannabis producers and 56 parent companies. It concluded that 84% of those leaders ...

Article by Sam Riches, Growth Op Working in family medicine for more than 20 years, Dr. Mark Ware has long witnessed the therapeutic benefits of cannabis, not only to address physical pain and discomfort, but also to treat mental health. Many of Dr. Ware’s patients have chronic pain and have exhausted conventional therapies. Cannabis, in some cases, has helped not ...

Article by Julia Veintrop, Cannabis Life Network Dr. Markus Roggen, PhD. has a doctorate in Chemistry. He is the founder and CEO of Complex Biotech Discovery Ventures LTD, a licensed cannabis research laboratory. Somehow, we managed to talk this guy into letting us ask him anything about weed and we certainly don’t hold back. It’s been ridiculous and fascinating and sometimes, the ...

Article by Laurie Weir, Smiths Falls Record News The use of medical cannabis by seniors in long-term care facilities across Ontario is being studied by Canopy Growth Corp. (CGC) in Smiths Falls. “The study began in October 2019 and while COVID has caused some delays with bringing on board new homes and patients, the study continues to be progressed,” said ...

Article by Craig T Lee, Study Finds The advancement of medicine is one of continuous discoveries. Sometimes, those notable advancements come from the most unlikely sources. A team in Canada finds cannabis, which causes plenty of legal debate in the United States, also contains a hidden substance which may lead to new antibiotics. A research team from McMaster University says ...

Article by Angela Stelmakowich, Growth Op Canadian researchers have found the oral synthetic cannabinoids nabilone and dronabinol contribute to negative respiratory health events, including death, in older people with chronic obstructive pulmonary disease (COPD). COPD covers two types of chronic diseases — namely emphysema chronic bronchitis — where the lung’s airways become swollen and partly blocked, reports The Lung Association. “COPD ...